Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2023

16-06-2022 | Primary Immunodeficiency

T Cell Abnormalities in X-Linked Agammaglobulinaemia: an Updated Review

Authors: Sanchi Chawla, Ankur Kumar Jindal, Kanika Arora, Rahul Tyagi, Manpreet Dhaliwal, Amit Rawat

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2023

Login to get access

Abstract

X-linked agammaglobulinaemia (XLA) is a primary immunodeficiency (PID) resulting from a defect in the B cell development. It has conventionally been thought that T cells play a major role in the development and function of the B cell compartment. However, it has also been shown that B cells and T cells undergo bidirectional interactions and B cells also influence the structure and function of the T cell compartment. Patients with XLA offer a unique opportunity to understand the effect of absent B cells on the T cell compartment. In this review, we provide an update on abnormalities in the T cell compartment in patients with XLA. Studies have shown impaired memory T cells, follicular helper T cells, T regulatory cells and T helper 17 in patients with XLA. In addition, these patients have also been reported to have abnormal delayed cell-mediated immune responses and vaccine-specific T cell-mediated immune responses; defective T helper cell polarization and impaired T cell receptor diversity. At present, the clinical significance of these T cell abnormalities has not been studied in detail. However, these abnormalities may result in an increased risk of viral infections, autoimmunity, autoinflammation and possibly chronic lung disease. Abnormal response to SARS-Cov2 vaccine in patients with XLA and prolonged persistence of SARS-Cov2 virus in the respiratory tract of these patients may be related to abnormalities in the T cell compartment.
Literature
8.
go back to reference Smith CI, Baskin B, Humire-Greiff P et al (1994) Expression of Bruton’s agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152:557–565CrossRefPubMed Smith CI, Baskin B, Humire-Greiff P et al (1994) Expression of Bruton’s agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152:557–565CrossRefPubMed
29.
go back to reference Kansas GS, Wood GS, Engleman EG (1985) Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8. J Immunol 134:3003–3006CrossRefPubMed Kansas GS, Wood GS, Engleman EG (1985) Maturational and functional diversity of human B lymphocytes delineated with anti-Leu-8. J Immunol 134:3003–3006CrossRefPubMed
31.
go back to reference Pituch-Noworolska A, Zwonarz K, Błaut-Szlósarczyk A et al (2013) T lymphocytes and NK cells in X-linked agammaglobulinemia. Przegl Lek 70:1048–1050PubMed Pituch-Noworolska A, Zwonarz K, Błaut-Szlósarczyk A et al (2013) T lymphocytes and NK cells in X-linked agammaglobulinemia. Przegl Lek 70:1048–1050PubMed
34.
go back to reference Scognamiglio P, Accapezzato D, Casciaro MA et al (1999) Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162:6681–6689CrossRefPubMed Scognamiglio P, Accapezzato D, Casciaro MA et al (1999) Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162:6681–6689CrossRefPubMed
37.
go back to reference Rozynska KE, Spickett GP, Millrain M et al (1989) Accessory and T cell defects in acquired and inherited hypogammaglobulinaemia. Clin Exp Immunol 78:1–6PubMedPubMedCentral Rozynska KE, Spickett GP, Millrain M et al (1989) Accessory and T cell defects in acquired and inherited hypogammaglobulinaemia. Clin Exp Immunol 78:1–6PubMedPubMedCentral
40.
go back to reference Macaulay AE, DeKruyff RH, Umetsu DT (1998) Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J Immunol (Baltimore, Md : 1950) 160:1694–700 Macaulay AE, DeKruyff RH, Umetsu DT (1998) Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J Immunol (Baltimore, Md : 1950) 160:1694–700
41.
go back to reference Langhorne J, Cross C, Seixas E et al (1998) A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci USA 95:1730–1734CrossRefPubMedPubMedCentral Langhorne J, Cross C, Seixas E et al (1998) A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci USA 95:1730–1734CrossRefPubMedPubMedCentral
61.
go back to reference Bateman EA, Ayers L, Sadler R, Lucas M, Roberts C, Woods A, et al (2012) T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 170(2):202-11 Bateman EA, Ayers L, Sadler R, Lucas M, Roberts C, Woods A, et al (2012) T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 170(2):202-11
Metadata
Title
T Cell Abnormalities in X-Linked Agammaglobulinaemia: an Updated Review
Authors
Sanchi Chawla
Ankur Kumar Jindal
Kanika Arora
Rahul Tyagi
Manpreet Dhaliwal
Amit Rawat
Publication date
16-06-2022
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2023
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-022-08949-7

Other articles of this Issue 1/2023

Clinical Reviews in Allergy & Immunology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.